Kasoha, M.; Steinbach, A.K.; Bohle, R.M.; Linxweiler, B.; Haj Hamoud, B.; Doerk, M.; Nigdelis, M.P.; Stotz, L.; Zimmermann, J.S.M.; Solomayer, E.-F.;
et al. Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients. Cancers 2024, 16, 419.
https://doi.org/10.3390/cancers16020419
AMA Style
Kasoha M, Steinbach AK, Bohle RM, Linxweiler B, Haj Hamoud B, Doerk M, Nigdelis MP, Stotz L, Zimmermann JSM, Solomayer E-F,
et al. Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients. Cancers. 2024; 16(2):419.
https://doi.org/10.3390/cancers16020419
Chicago/Turabian Style
Kasoha, Mariz, Anna K. Steinbach, Rainer M. Bohle, Barbara Linxweiler, Bashar Haj Hamoud, Merle Doerk, Meletios P. Nigdelis, Lisa Stotz, Julia S. M. Zimmermann, Erich-Franz Solomayer,
and et al. 2024. "Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients" Cancers 16, no. 2: 419.
https://doi.org/10.3390/cancers16020419
APA Style
Kasoha, M., Steinbach, A. K., Bohle, R. M., Linxweiler, B., Haj Hamoud, B., Doerk, M., Nigdelis, M. P., Stotz, L., Zimmermann, J. S. M., Solomayer, E.-F., Kaya, A. C., & Radosa, J. C.
(2024). Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients. Cancers, 16(2), 419.
https://doi.org/10.3390/cancers16020419